PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

ViiV posts positive long-term data for two-drug HIV regimen Dovato

GlaxoSmithKline subsidiary ViiV Healthcare has reported three-year data for its two-drug HIV regimen Dovato, with hopes that the long-term data could encourage clini...
Continue Reading →
News

CRISPR, the revolutionary genetic ‘scissors,’ honored by Chemistry Nobel

This year’s Nobel Prize in Chemistry has been awarded to two scientists who transformed an obscure bacterial immune mechanism, commonly called CRISPR, into a to...
Continue Reading →
News

£70 Million Government PPE Contract for Small ‘Luxury Packaging’ Firm

The Government has awarded a £70 million contract for the supply of face masks to a small luxury packaging company. Documents released in late September show that ...
Continue Reading →
News

Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance

         Systematic direct cell conversion platform published in Cell Systems ·     &nbs...
Continue Reading →
News

Arranta Bio set to boost manufacturing for growing pipeline of microbiome drugs

Arranta Bio, a contract manufacturer formed last year to help companies produce microbiome therapies, has finished building manufacturing suites at a site ...
Continue Reading →
News

After trial failure, Genfit cuts staff and gives up on experimental NASH drug

Genfit, a France-based biotech that has lost about three-quarters of its value since announcing a crucial study failure in May, plans to cut 40% of its staff an...
Continue Reading →
News

Private equity-backed Covis to buy AMAG Pharma in $650M deal

Covis Group, a specialty pharmaceuticals company backed by private equity firm Apollo Global Management, has agreed to buy AMAG Pharmaceutical in a deal valued at ap...
Continue Reading →
News

Pharmacquired: Splashy deals believe a shallow pool of heart drugs left to acquire

Two big deals for heart drugs in less than a year might give the impression that more could soon follow. But what Bristol Myers Squibb did this Monday with its&nbs...
Continue Reading →
News

J&J moving to settle 1,000 talc lawsuits for more than $100M: Bloomberg

Battling more than 20,000 lawsuits alleging its talc powder causes cancer, Johnson & Johnson is moving to settle more than 1,000 suits for about $100 million, Bl...
Continue Reading →
News

Just days after buyout notice, AMAG faces FDA push to withdraw premature-birth med Makena

After years of proxy squabbles and FDA scrutiny of a key drug, troubled AMAG Pharmaceuticals appeared to be in the clear with a buyout deal signed last week. But the...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026